Trimedyne, Inc. (OTCMKTS:TMED – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.25 and traded as low as $4.25.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Laufey Last week Weeks at no. 1 Weeks on chart Laufey/AWAL Greatest gainer this week Gains In Performance Week of April 5, 2025 click to see more ...

ROSE & Bruno Mars Last week Weeks at no. 1 Weeks on chart Week of April 5, 2025 click to see more Greatest gainer this week Gains In Performance Highest ranking debut ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Blackmagic Design will now be selling a body-only version of its new URSA Cine 17K 65 for $21,995 USD. The body only model is ...